-
Photodynamic Therapy in Unresectable Cholangiocarcinoma: Not for the Uncommitted
-
Jayant P. Talreja, Marisa DeGaetani, Kristi Ellen, Timothy Schmitt, Monica Gaidhane, Michel Kahaleh
-
Clin Endosc 2013;46(4):390-394. Published online July 31, 2013
-
DOI: https://doi.org/10.5946/ce.2013.46.4.390
-
-
 Abstract
 PDF PubReader ePub
- Background/Aims
Photodynamic therapy (PDT) in unresectable cholangiocarcinoma has been associated with improved survival. We report a single tertiary care center experience over the past 6 years. MethodsFifty-five patients with unresectable cholangiocarcinoma received PDT between 2004 and 2010. Plastic stents were placed after PDT to prevent cholangitis. ResultsTwenty-seven patients (49%) showed Bismuth type IV, 22 (41%) showed Bismuth type III, and six (10%) showed Bismuth type I and II. Twenty patients (37%) received chemotherapy and radiation therapy, five (9%) received chemotherapy only; and one (2%) received radiation therapy only. Mean number of PDT sessions was 1.9±1.5 sessions (range, 1 to 9). Mean survival duration was 293±266 days (median, 190; range, 25 to 1,332). PDT related complications included three (5%) facial burn, three (5%) photosensitivity, and two (3%) rash. Kaplan-Meier analysis comparing the survival means of patients who received PDT and chemotherapy/radiation therapy (median survival 257 days; 95% confidence interval [CI], 166 to 528) versus who received PDT only (median survival 183 days; 95% CI, 129 to 224) showed no significant difference (log-rank p=0.20). ConclusionsPDT has a measurable impact on survival in unresectable cholangiocarcinoma but requires aggressive stenting posttherapy.
-
Citations
Citations to this article as recorded by  - Ablation Therapy of the Biliary Tree
Marina Kim, Darshan Parekh, Michel Kahaleh
Journal of Clinical Gastroenterology.2024;[Epub] CrossRef - Ablative Therapy in Non-HCC Liver Malignancy
Tyler P. Robinson, Travis Pebror, Matthew E. Krosin, Leonidas G. Koniaris
Cancers.2023; 15(4): 1200. CrossRef - Benefits and safety of photodynamic therapy in patients with hilar cholangiocarcinoma: A meta-analysis
Pengcheng Chen, Ting Yang, Peidong Shi, Jiangbo Shen, Qingchun Feng, Jingen Su
Photodiagnosis and Photodynamic Therapy.2022; 37: 102712. CrossRef - Photodynamic Therapy (PDT), Radiofrequency Ablation (RFA) With Biliary Stents in Palliative Treatment of Unresectable Extrahepatic Cholangiocarcinoma
Babu P. Mohan, Saurabh Chandan, Shahab R. Khan, Lena L. Kassab, Suresh Ponnada, Everson L.A. Artifon, Jose P. Otoch, Stephanie McDonough, Douglas G. Adler
Journal of Clinical Gastroenterology.2022; 56(2): e153. CrossRef - Comparing palliative treatment options for cholangiocarcinoma: photodynamic therapy vs. radiofrequency ablation
Tayyaba Mohammad, Michel Kahaleh
Clinical Endoscopy.2022; 55(3): 347. CrossRef - New approach to the treatment of cancer of large duodenal papilla and extrahepatic bile ducts with photodynamic therapy
E. P. Stranadko, A. V. Baranov, V. A. Duvansky, A. I. Lobakov, V. A. Morokhotov, M. V. Riabov
Experimental and Clinical Gastroenterology.2022; (5): 78. CrossRef - Endoscopic palliation of malignant biliary obstruction
Andrew Canakis, Michel Kahaleh
World Journal of Gastrointestinal Endoscopy.2022; 14(10): 581. CrossRef - Endoscopic Retrograde Cholangiopancreatography-Guided Ablation for Cholangiocarcinoma
Ross C.D. Buerlein, Andrew Y. Wang
Gastrointestinal Endoscopy Clinics of North America.2019; 29(2): 351. CrossRef - Photodynamic Therapy Plus Chemotherapy Compared with Photodynamic Therapy Alone in Hilar Nonresectable Cholangiocarcinoma
Robert Wentrup, Nicola Winkelmann, Andrey Mitroshkin, Matthias Prager, Winfried Voderholzer, Guido Schachschal, Christian J, rgensen, Carsten B, ning
Gut and Liver.2016;[Epub] CrossRef - Efficacy and safety of photodynamic therapy for unresectable cholangiocarcinoma: A meta-analysis
Yi Lu, Lei Liu, Jia-chuan Wu, Li-ke Bie, Biao Gong
Clinics and Research in Hepatology and Gastroenterology.2015; 39(6): 718. CrossRef - Biliary Tumor Ablation with Photodynamic Therapy and Radiofrequency Ablation
Ioana Smith, Michel Kahaleh
Gastrointestinal Endoscopy Clinics of North America.2015; 25(4): 793. CrossRef - The Role of Endoscopy in the Diagnosis and Management of Cholangiocarcinoma
Ajaypal Singh, Uzma D. Siddiqui
Journal of Clinical Gastroenterology.2015; 49(9): 725. CrossRef - Role of photodynamic therapy and intraductal radiofrequency ablation in cholangiocarcinoma
Janaki Patel, Nada Rizk, Michel Kahaleh
Best Practice & Research Clinical Gastroenterology.2015; 29(2): 309. CrossRef - Impact of Radiofrequency Ablation on Malignant Biliary Strictures: Results of a Collaborative Registry
Reem Z. Sharaiha, Amrita Sethi, Kristen R. Weaver, Tamas A. Gonda, Raj J. Shah, Norio Fukami, Prashant Kedia, Nikhil A. Kumta, Carlos M. Rondon Clavo, Michael D. Saunders, Jorge Cerecedo-Rodriguez, Paola Figueroa Barojas, Jessica L. Widmer, Monica Gaidhan
Digestive Diseases and Sciences.2015; 60(7): 2164. CrossRef - Randomised phase II trial of photodynamic therapy plus oral fluoropyrimidine, S-1, versus photodynamic therapy alone for unresectable hilar cholangiocarcinoma
Do Hyun Park, Sang Soo Lee, So Eun Park, Jae Lyun Lee, Jun Ho Choi, Hee Jung Choi, Ji Woong Jang, Hyoung Jung Kim, Jun Bum Eum, Dong-Wan Seo, Sung Koo Lee, Myung-Hwan Kim, Jung Bok Lee
European Journal of Cancer.2014; 50(7): 1259. CrossRef - Is There Any Evidence for a Role of Local Treatment in Cholangiocarcinoma?
Arndt Vogel, Oliver Dudeck
Visceral Medicine.2014; 30(4): 254. CrossRef
-
6,853
View
-
65
Download
-
16
Crossref
|
KSGE
